Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium

Current Diabetes Reports

Volumn 3, Issue 4, 2003, Pages 279-288

  Vincent, Michelle A ^b   Montagnani, Monica ^b   Quon, Michael J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CBL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENISTEIN; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN SERINE KINASE; PROTEIN SHC; RAMIPRIL; WORTMANNIN; GLUCOSE;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME SYNTHESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HEMODYNAMICS; HORMONAL REGULATION; HUMAN; HYPERTENSION; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIMB BLOOD FLOW; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MUSCLE BLOOD FLOW; MUSCLE CAPILLARY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; BLOOD FLOW; HOMEOSTASIS; LIMB; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; VASCULAR DISEASE; VASCULARIZATION;

ANIMALS; ENDOTHELIUM, VASCULAR; EXTREMITIES; GLUCOSE; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; VASCULAR DISEASES; VASODILATION;

EID: 0141671792     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-003-0018-9     Document Type: Review

References (75)

1. Simionescu M, Gafencu A, Antohe F: Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 2002, 57:269-288.
2. Zeng G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 1996, 98:894-898.
3. Zeng G, Nystrom FH, Ravichandran LV, et al.: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545.
4. Montagnani M, Chen H, Barr VA, et al.: Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem 2001, 276:30392-30398.
5. Montagnani M, Ravichandran LV, Chen H, et al.: Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 2002, 16:1931-1942.
6. Baron AD: Hemodynamic actions of insulin. Am J Physiol 1994, 267:E187-E202.
7. Vincent MA, Dawson D, Clark AD, et al.: Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 2002, 51:42-48.
8. Vincent MA, Barrett EJ: Insulin-induced capillary recruitment precedes changes in skeletal muscle glucose uptake. Diabetes 2002, 51(suppl 2):A31.
9. Vincent MA, Clerk LH, Barrett E: Skeletal muscle microvascular recruitment is more sensitive than femoral blood flow or glucose disposal. Diabetes 2003, 52(suppl 2):A205.
10. Vincent MA, Lindner JR, Barrett EJ, et al.: Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol 2003, 285:E123-E130.
11. Montagnani M, Quon MJ: Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab 2000, 2:285-292.
12. Stuehr DJ: Mammalian nitric oxide synthases. Biochim Biophys Acta 1999, 1411:217-230.
13. Michel JB, Feron O, Sacks D, et al.: Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+ calmodulin and caveolin. J Biol Chem 1997, 272:15583-15586.
14. Nystrom FH, Quon MJ: Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal 1999, 11:563-574.
15. White MF, Yenush L: The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Curr Top Microbiol Immunol 1998, 228:179-208.
16. Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al.: Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001, 70:535-602.
17. Toker A, Newton AC: Cellular signaling: pivoting around PDK-1. Cell 2000, 103:185-188.
18. Chen H, Nystrom FH, Dong LQ, et al.: Insulin stimulates increased catalytic activity of phosphoinositide-dependent kinase-1 by a phosphorylation-dependent mechanism. Biochemistry 2001, 40:11851-11859.
19. Vecchione C, Maffei A, Colella S, et al.: Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002, 51:168-173.
20. Dimmeler S, Fleming I, Fisslthaler B, et al.: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
21. Baron AD, Brechtel-Hook G, Johnson A, et al.: Effect of perfusion rate on the time course of insulin-mediated skeletal muscle glucose uptake. Am J Physiol 1996, 271:E1067-1072.
22. Rattigan S, Clark MG, Barrett EJ: Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 1997, 46:1381-1388.
23. Dawson D, Vincent MA, Barrett EJ, et al.: Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol 2002, 282:E714-E720.
24. Zhang L, Richards SM, Rattigan S, et al.: Capillary recruitment in muscle is a highly sensitive event in insulin action in vivo. Diabetes 2003, 52(suppl 2):A206.
25. Coggins M, Lindner J, Rattigan S, et al.: Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001, 50:2682-2690.
26. Scherrer U, Randin D, Vollenweider P, et al.: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-2515.
27. Hillier TA, Fryburg DA, Jahn LA, et al.: Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm. Am J Physiol 1998, 274:E1067-E1074.
28. Steinberg HO, Brechtel G, Johnson A, et al.: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172-1179.
29. Chen YL, Messina EJ: Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Physiol 1996, 270:H2120-H2124.
30. Yki-Jarvinen H, Utriainen T: Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998, 41:369-379.
31. Cardillo C, Nambi SS, Kilcoyne CM, et al.: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999, 100:820-825.
32. Mather KJ, Mirzamohammadi B, Lteif A, et al.: Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002, 51:3517-3523.
33. Anderson EA, Hoffman RP, Balon TW, et al.: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246-2252.
34. Sartori C, Trueb L, Nicod P, et al.: Effects of sympathectomy and nitric oxide synthase inhibition on vascular actions of insulin in humans. Hypertension 1999, 34:586-589.
35. Creager MA, Liang CS, Coffman JD: Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985, 235:709-714.
36. Vierhapper H: Effect of exogenous insulin on blood pressure regulation in healthy and diabetic subjects. Hypertension 1985, 7:1149-1153.
37. Quon MJ, Chen H, Ing BL, et al.: Roles of 1-phosphatidylinositol 3-kinase and ras in regulating translocation of GLUT4 in transfected rat adipose cells. Mol Cell Biol 1995, 15:5403-5411.
38. Quon MJ, Chen H, Lin CH, et al.: Effects of overexpressing wild-type and mutant PDGF receptors on translocation of GLUT4 in transfected rat adipose cells. Biochem Biophys Res Commun 1996, 226:587-594.
39. Huang PL, Huang Z, Mashimo H, et al.: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242.
40. Duplain H, Burcelin R, Sartori C, et al.: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001, 104:342-345.
41. Shankar RR, Wu Y, Shen HQ, et al.: Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000, 49:684-687.
42. Tamemoto H, Kadowaki T, Tobe K, et al.: Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994, 372:182-186.
43. Abe H, Yamada N, Kamata K, et al.: Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 1998, 101:1784-1788.
44. Vicent D, Ilany J, Kondo T, et al.: The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003, 111:1373-1380.
45. Renkin EM: Control of microcirculation and blood-tissue exchange. In Handbook of Physiology. The Cardiovascular System IV. Microcirculation. Edited by Renkin EM, et al. Bethesda, MD: American Physiological Society; 1984:627-687.
46. Grubb B, Snarr JF: Effect of flow rate and glucose concentration on glucose uptake rate by the rat limb. Proc Soc Exp Biol Med 1977, 154:33-36.
47. Rattigan S, Clark MG, Barrett EJ: Acute vasoconstriction-induced insulin resistance in rat muscle in vivo. Diabetes 1999, 48:564-569.
48. Clerk LH, Rattigan S, Clark MG: Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002, 51:1138-1145.
49. Wallis MG, Wheatley CM, Rattigan S, et al.: Insulin-mediated hemodynamic changes are impaired in muscle of Zucker obese rats. Diabetes 2002, 51:3492-3498.
50. Rattigan S, Wallis MG, Youd JM, et al.: Exercise training improves insulin-mediated capillary recruitment in association with glucose uptake in rat hindlimb. Diabetes 2001, 50:2659-2665.
51. Clark MG, Wallis MG, Barrett EJ, et al.: Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 2003, 284:E241-E258.
52. Laakso M, Edelman SV, Brechtel G, et al.: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992, 41:1076-1083.
53. McIntyre EA, Walker M: Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. Clin Endocrinol (Oxf) 2002, 57:303-311.
54. Karam JH: Reversible insulin resistance in non-insulin-dependent diabetes mellitus. Horm Metab Res 1996, 28:440-444.
55. Paolisso G, Giugliano D: Oxidative stress and insulin action: is there a relationship? Diabetologia 1996, 39:357-363.
56. Jiang ZY, Lin YW, Clemont A, et al.: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999, 104:447-457.
57. Cheng TH, Shih NL, Chen SY, et al.: Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J Mol Cell Cardiol 2001, 33:1805-1814.
58. Montagnani M, Golovchenko I, Kim I, et al.: Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002, 277:1794-1799.
59. Begum N, Sandu OA, Ito M, et al.: Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 2002, 277:6214-6222.
60. Katakam PV, Ujhelyi MR, Hoenig ME, et al.: Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 1998, 275:R788-792.
61. Williams SB, Cusco JA, Roddy MA, et al.: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996, 27:567-574.
62. Tack CJ, Smits P, Willemsen JJ, et al.: Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 1996, 45:15-22.
63. Hardin DS, Azzarelli B, Edwards J, et al.: Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles. J Clin Endocrinol Metab 1995, 80:2437-2446.
64. Coggins M, Fasy E, Lindner J, et al.: Obesity blunts insulin's action to recruit capillaries in human skeletal muscle. Diabetes 2000, 49:A237.
65. Cnop M, Havel PJ, Utzschneider KM, et al.: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
66. Mineo C, Yuhanna IS, Quon MJ, et al.: High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem 2003, 278:9142-9149.
67. Chen H, Montagnani M, Funahashi T, et al.: Adiponectin stimulates production of nitric oxide in endothelial cells through AMPK-dependent phosphorylation of eNOS at Ser1179. Diabetes 2003, 53(suppl 2):A1839.
68. Hsueh WA, Law RE: PPARgamma and atherosclerosis: effects on cell growth and movement. Arterioscler Thromb Vasc Biol 2001, 21:1891-1895.
69. Fujishima S, Ohya Y, Nakamura Y, et al.: Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am J Hypertens 1998, 11:1134-1137.
70. Mather KJ, Verma S, Anderson TJ: Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 2001, 37:1344-1350.
71. Nawano M, Anai M, Funaki M, et al.: Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Metabolism 1999, 48:1248-1255.
72. Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145-153.
73. Paniagua JA, Lopez-Miranda J, Escribano A, et al.: Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Diabetes 2002, 51:2596-2603.
74. Omori H, Nagashima H, Tsurumi Y, et al.: Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br J Clin Pharmacol 2002, 54:395-399.
75. Laufs U, La Fata V, Plutzky J, et al.: Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998, 97:1129-1135.